| 000 | 01199 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513075011.0 | ||
| 264 | 0 | _c19930922 | |
| 008 | 199309s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aProkurat, S | |
| 245 | 0 | 0 |
_aGanciclovir in cytomegalovirus prophylaxis in high-risk pediatric renal transplant recipients. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cAug 1993 |
||
| 300 |
_a2577 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xepidemiology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aGanciclovir _xtherapeutic use |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 |
_aGraft Rejection _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 |
_aImmunoglobulin M _xblood |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aDrabik, E | |
| 700 | 1 | _aGrenda, R | |
| 700 | 1 | _aVogt, E | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 25 _gno. 4 _gp. 2577 |
|
| 999 |
_c8394377 _d8394377 |
||